Capricor Therapeutics Inc CAPR:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:20 PM EDT
5.01UNCH (UNCH)
Volume
4,528
Close
5.01quote price arrow down-0.04 (-0.79%)
Volume
349,497
52 week range
2.68 - 8.22
Loading...
  • Open5.00
  • Day High5.28
  • Day Low4.87
  • Prev Close5.05
  • 52 Week High8.22
  • 52 Week High Date08/28/23
  • 52 Week Low2.68
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap157.83M
  • Shares Out31.50M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta4.08
  • YTD % Change2.45

KEY STATS

  • Open5.00
  • Day High5.28
  • Day Low4.87
  • Prev Close5.05
  • 52 Week High8.22
  • 52 Week High Date08/28/23
  • 52 Week Low2.68
  • 52 Week Low Date11/10/23
  • Market Cap157.83M
  • Shares Out31.50M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta4.08
  • YTD % Change2.45

RATIOS/PROFITABILITY

  • EPS (TTM)-0.87
  • P/E (TTM)-5.75
  • Fwd P/E (NTM)-6.04
  • EBITDA (TTM)-23.009M
  • ROE (TTM)-129.63%
  • Revenue (TTM)25.178M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-88.52%
  • Debt To Equity (MRQ)14.94%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Capricor Therapeutics Inc

 

Content From Our Affiliates

Profile

MORE
Capricor Therapeutics, Inc. is a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment and prevention of rare diseases. The Company's program is focused on the development and commercialization of a cell therapy technology comprised of cardiosphere-derived cells (CDCs) for the treatment of Duchenne muscular dystrophy (DMD). Its lead product candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy. CAP-1002 is advancing...
Frank Litvack M.D.
Executive Chairman of the Board
Linda Marban Ph.D.
President, Chief Executive Officer, Director
Anthony Bergmann
Chief Financial Officer
Karen Krasney J.D.
Executive Vice President, General Counsel
Address
8840 Wilshire Blvd, 2nd Floor
Beverly Hills, CA
90211
United States